Hospital risk management at the time of Covid-19: An analysis of the Lombardy Region

Journal title MECOSAN
Author/s Alessandro Capocchi, Paola Orlandini, Stefano Amelio
Publishing Year 2021 Issue 2021/118 Language English
Pages 20 P. 97-116 File size 280 KB
DOI 10.3280/MESA2021-118005
DOI is like a bar code for intellectual property: to have more infomation click here

Below, you can see the article first page

If you want to buy this article in PDF format, you can do it, following the instructions to buy download credits

Article preview

FrancoAngeli is member of Publishers International Linking Association, Inc (PILA), a not-for-profit association which run the CrossRef service enabling links to and from online scholarly content.

Covid-19 has imposed a rethinking of risk management systems in the healthcare sector. The aim of this paper is to investigate how the risk has been and is managed by the healthcare organizations, on the basis of regional directives. The analysis focuses on the health system of the Lombardy Region. In particular, the authors focused on the resolutions adopted by the Lombardy Region in the acute phase of the pandemic (2 March 2020-12 May 2020) with the aim of rebuilding the system put in place by the Region for risk prevention and management. Thanks to the resolutions, the Lombardy Region has established a risk management system, consisting of a surveillance system and an emergency management system that seems to have led to positive consequences.

Keywords: Covid-19, Emergency management system, Healthcare sector, Lombardy, Resolutions, Risk management, Surveillance system.

  1. Gulino M., Vergallo G. M., & Frati P. (2011). The relevance of clinical risk management. Medicina nei secoli, 23(3): 901-914.
  2. Allegrini M., & D’Onza G. (2011). Corporate governance, risk management e responsabilita sociale fra presente e futuro dell’attivita di internal auditing. Management control. DOI: 10.3280/MACO2011-001007
  3. Amran A., Bin A. M. R., & Hassan B. C. H. M. (2009). Risk reporting. Managerial Auditing Journal, 24(1): 39-57. DOI: 10.1108/02686900910919893
  4. Armocida B., Formenti B., Ussai S., Palestra F., & Missoni E. (2020). The Italian health system and the COVID-19 challenge. The Lancet Public Health, 5(5): e253. DOI: 10.1016/S2468-2667(20)30074-8
  5. Aven T. (2018). How the integration of System 1-System 2 thinking and recent risk perspectives can improve risk assessment and management. Reliability Engineering & System Safety, 180: 237-244.
  6. Barclay L. (2007). Improvements needed in infection control, survey suggests. Nursing, 28-36.
  7. Bates D. W., Leape L. L., & Petrycki S. (1993). Incidence and preventability of adverse drug events in hospitalized adults. Journal of general internal medicine, 8(6): 289-294.
  8. Baxter R. L., Baxter H. C., Campbell G. A., Grant K., Jones A., Richardson P., & Whittaker G. (2006).
  9. Quantitative analysis of residual protein contamination on reprocessed surgical instruments. Journal of hospital infection, 63(4): 439-444. Belingheri M., Paladino M. E., & Riva M. A.
  10. (2020). COVID-19: health prevention and control in non-healthcare settings. Occupational Medicine, 70(2): 82-83.
  11. Bizzarri G., Dario C., Jseppi R., & Roberti G. (2014). Lo sviluppo del sistema di controllo interno nelle aziende sanitarie. Come ridurre i rischi amministrativo-contabili e migliorare le performance: Come ridurre i rischi amministrativo-contabili e migliorare le performance. Milano: FrancoAngeli.
  12. Borgonovi E. (2020). Crisi Covid-19 come fonte di apprendimento. Mecosan, 113: 5-7. DOI: 10.3280/MESA2020-113001
  13. Brannigan E. T., Murray E., & Holmes A. (2009). Where does infection control fit into a hospital management structure?. Journal of Hospital Infection, 73(4): 392-396.
  14. Brindle M. E., & Gawande A. (2020). Managing COVID-19 in surgical systems. Annals of Surgery, 272(1): e1-e2. DOI: 10.1097/SLA.0000000000003923
  15. Brusoni M., Trinchero E., & Vescia M. (2014). La gestione del rischio in sanita: elementi organizzativi e gestionali. In: Aleo S., De Matteis R., & Vecchio G. (Eds.). La responsabilita in ambito sanitario. Padova: CEDAM.
  16. Cagliano A. C., Grimaldi S., & Rafele C. (2011). A systemic methodology for risk management in healthcare sector. Safety Science, 49(5): 695-708.
  17. Canitano S., Ghirardini A., Migliazza M., & Trinchero E. (2010). Risk management, strumenti e cultura organizzativa per il governo della patient safety: dalla teoria alla pratica. Mecosan, 76: 89.
  18. Cao Y., Li Q., Chen J., Guo X., Miao C., Yang H., & Li L. (2020). Hospital emergency management plan during the COVID‐19 epidemic. Academic Emergency Medicine, 27(4): 309-311.
  19. Capocchi A., Orlandini P., Pierotti M., Luzzi L., & Minetti L. (2019). Risk Management in the Healthcare Sector and the Important Role of Education and Training Activities: The Case of Regione Lombardia. International Journal of Business and Management, 14(1): 180-191.
  20. Cesana G., Fornari C., Chiodini V., Madotto F., Merlino L., & Mantovani L. G. (2011). DENALI: il Data Warehouse di Sanita Pubblica della Regione Lombardia. Farmeconomia. Health economics and therapeutic pathways, 12(2S): 19-23.
  21. Cheng V. C., Chan J. F., To K. K., & Yuen K. Y. (2013). Clinical management and infection control of SARS: lessons learned. Antiviral research, 100(2): 407-419.
  22. Cosmi L., & Del Vecchio M. (2004). Lo sviluppo della funzione risk management nelle aziende sanitarie: una prospettiva economico-aziendale. Difesa sociale, 1: 7-18.
  23. Degani L., Lopez A., Monturano M., Rinaldi O., & Ubezio M. (2013). Principi di risk management nei servizi sanitari e socio-sanitari. Maggioli Editore.
  24. D’Onza G. (2008). Il sistema di controllo interno nella prospettiva del risk management, Vol. 81. Milano: Giuffre editore.
  25. Duijm N. J. (2015). Recommendations on the use and design of risk matrices. Safety Science, 76: 21-31.
  26. Dwosh H. A., Hong H. H., Austgarden D., Herman S., & Schabas R. (2003). Identification and containment of an outbreak of SARS in a community hospital. Cmaj, 168(11): 1415-1420.
  27. Ferioli M., Cisternino C., Leo V., Pisani L., Palange P., & Nava S. (2020). Protecting healthcare workers from SARS-CoV-2 infection: practical indications. European Respiratory Review, 29(155). DOI: 10.1183/16000617.0068-2020
  28. Ferrari A., Odone A., Florindo N., Mandelli P. G., & Signorelli C. (2017). La formazione nel risk management nelle aziende sanitarie alla luce delle novita legislative. Acta Bio Medica: Atenei Parmensis, 88(3): 365.
  29. Forster P., Forster L., Renfrew C., & Forster M. (2020). Phylogenetic network analysis of SARSCoV-2 genomes. Proceedings of the National Academy of Sciences, 117(17): 9241-9243.
  30. Gan W. H., Lim J. W., & David K. O. H. (2020). Preventing intra-hospital infection and transmission of COVID-19 in healthcare workers. Safety and Health at Work, 11(2): 241-243.
  31. Gasmi A., Noor S., Tippairote T., Dadar M., Menzel A., & Bjorklund G. (2020). Individual risk management strategy and potential therapeutic options for the COVID-19 pandemic. Clinical Immunology, 108409.
  32. Gazzola P., Amelio S., & Figus A. (2020). The Double Relationship Between Risk Management and CSR in the Italian Healthcare Sector: The Case of the Lombard “Health Protection Agencies” (ATS). In: Contemporary Trends and Challenges in Finance, pp. 101-111. Cham: Springer.
  33. Gopalakrishna G., Choo P., Leo Y. S., Tay B. K., Lim Y. T., Khan A. S., & Tan C. C. (2004). SARS transmission and hospital containment. Emerging infectious diseases, 10(3): 395-400.
  34. Grasselli G., Pesenti A., & Cecconi M. (2020). Critical care utilization for the COVID-19 outbreak in Lombardy, Italy: early experience and forecast during an emergency response. Jama, 323(16): 1545-1546.
  35. Grasselli G., Zangrillo A., Zanella A., Antonelli M., Cabrini L., Castelli A., & Iotti G. (2020). Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy Region, Italy. Jama, 323(16): 1574-1581.
  36. Gregis R., & Marazzi L. (2003). Il risk management nelle aziende sanitarie. Milano: FrancoAngeli. Guarner J. (2020). Three emerging coronaviruses in two decades: the story of SARS, MERS, and now COVID-19. Am J Clin Pathol, 153: 420-421.
  37. Haley R. W., Culver D. H., White J. W., Morgan W. M., Emori T. G., Munn V. P., & Hooton T. M. (1985). The efficacy of infection surveillance and control programs in preventing nosocomial infections in us hospitals. American journal of epidemiology, 121(2): 182-205.
  38. Harbarth S., Sax H., & Gastmeier P. (2003). The preventable proportion of nosocomial infections: an overview of published reports. Journal of Hospital infection, 54(4): 258-266.
  39. Harrington S. E., & Niehaus G. (2003). Capital, corporate income taxes, and catastrophe insurance. Journal of Financial Intermediation, 12(4): 365-389.
  40. Imai T., Takahashi K., Hoshuyama T., Hasegawa N., Lim M. K., & Koh D. (2005). SARS risk perceptions in healthcare workers, Japan. Emerging Infectious Diseases, 11(3): 404-410.
  41. Jose A., & Lee S. M. (2007). Environmental reporting of global corporations: A content analysis based on website disclosures. Journal of Business Ethics, 72(4): 307-321.
  42. Kakodkar P., Kaka N., & Baig M. N. (2020). A comprehensive literature review on the clinical presentation, and management of the pandemic coronavirus disease 2019 (COVID-19). Cureus, 12(4): e7560.
  43. Kaya G. K., Ward J., & Clarkson J. (2019). A review of risk matrices used in acute hospitals in England. Risk Analysis, 39(5): 1060-1070.
  44. Koh D., Lim M. K., Chia S. E., Ko S. M., Qian F., Ng V., ... & Ng W. (2005). Risk Perception and Impact of Severe Acute Respiratory Syndrome (SARS) on Work and Personal Lives of Healthcare Workers in Singapore What Can We Learn?. Medical Care, 43(7): 676-682.
  45. Kohn L. T., & Corrigan J. M. (1999). To err is human: Building a safer health system. In: Donaldson M.S. (eds). Committee on Quality of Health Care in America. Washington, DC: Institute of Medicine.
  46. Kohn L. T., Corrigan J. M., & Donaldson M. S. (2000). Errors in health care: a leading cause of death and injury. In: To err is human: Building a safer health system. National Academies Press (US).
  47. Krippendorff K. (2018). Content analysis: An introand duction to its methodology. Los Angeles: Sage publications.
  48. Lajili K., & Zeghal D. (2005). A content analysis of risk management disclosures in Canadian annual reports. Canadian Journal of Administrative Sciences/Revue Canadienne des Sciences de l’Administration, 22(2): 125-142.
  49. La Regina G. E. M., Romano E., Tardivo S., & Trinchero E. (2019). Rischio clinico in sanita e prevenzione dei rischi del paziente ricoverato in ospedale. Italian Journal of Medicine, 7(1): 1-156.
  50. Lee S., Yeo J., & Na C. (2020). Learning from the past: Distributed cognition and crisis management capabilities for tackling COVID-19. The American Review of Public Administration, 50(6-7): 729-735. DOI: 10.1177/0275074020942412
  51. Liu Q., Luo D., Haase J. E., Guo Q., Wang X. Q., Liu S., ... & Yang B. X. (2020). The experiences of health-care providers during the COVID-19 crisis in China: a qualitative study. The Lancet Global Health, 8(6): e790-e798.
  52. Livingston E., & Bucher K. (2020). Coronavirus disease 2019 (COVID-19) in Italy. Jama, 323(14): 1335-1335.
  53. Loutfy M. R., Wallington T., Rutledge T., Mederski B., Rose K., Kwolek S., ... & Glassman E. (2004). Hospital preparedness and SARS. Emerging infectious diseases, 10(5): 771.
  54. Lucas D. (1997). The causes of human error. In: Redmill R (Ed). Human Factors in Safety Critical Systems. Oxford: Butterworth Heinemann, 37-65.
  55. Mangram A. J., Horan T. C., Pearson M. L., Silver L. C., Jarvis W. R., & Hospital Infection Control Practices Advisory Committee (1999). Guideline for prevention of surgical site infection, 1999. American journal of infection control, 27(2): 97-134.
  56. Mash B. (2020). Primary care management of the coronavirus (COVID-19). South African Family Practice, 62(1): e1-e4.
  57. McAleer M. (2020). Prevention is better than the cure: Risk management of COVID-19. South African Family Practice, 62(1): e1-e4.
  58. Melato M., Santin C., & Zigrino F. (2008). Da individuale a sociale: una proposta di gestione del rischio in sanita. Mecosan, 17(66): 75-85.
  59. Messano G., De Bono V., Di Folco F., & Marsella L. (2014). Past and present of risk management in healthcare. SANITA PUBBLICA, 421-427.
  60. Nesmith J. (2003). SARS economic impact soared above health costs. The Atlanta Journal-Constitution, 1.
  61. Peeri N. C., Shrestha N., Rahman M. S., Zaki R., Tan Z., Bibi S., ... & Haque U. (2020). The SARS, MERS and novel coronavirus (COVID-19) epidemics, the newest and biggest global health threats: what lessons have we learned?. International journal of epidemiology, 49(3): 717-726.
  62. Perna A., Perrella G., Perna C., & Vacchiano G. (2010). L’affare rischio clinico. Trasferimento assicurativo e gestione diretta: Trasferimento assicurativo e gestione diretta. Milano: FrancoAngeli.
  63. Pittiruti M., & Scoppettuolo G. (2017). La prevenzione delle infezioni del sito chirurgico e le linee guida. Impatto e prevenzione delle infezioni del sito chirurgico: una proposta di lavoro sulle Linee guida, 11. Reason J. T. (2001). Understanding adverse events, the human factor. I Vincent C. Clinical risk management. Enhancing patient safety, 2.
  64. Sale D. (2005). Understanding Clinical Governance and Quality Assurance. New York: Palgrave Macmillan.
  65. Smith E. D., Siefert W. T., & Drain D. (2009). Risk matrix input data biases. Systems Engineering, 12(4): 344-360.
  66. Smith R. D. (2006). Responding to global infectious disease outbreaks: lessons from SARS on the role of risk perception, communication and management. Social science & medicine, 63(12): 3113-3123.
  67. Spina S., Marrazzo F., Migliari M., Stucchi R., Sforza A., & Fumagalli R. (2020). The response of Milan’s Emergency Medical System to the COVID-19 outbreak in Italy. The Lancet, 395(10227): e49-e50. DOI: 10.1016/S0140-6736(20)30493-1
  68. Spinelli A., & Pellino G. (2020). COVID‐19 pandemic: perspectives on an unfolding crisis. The British Journal of Surgery.
  69. Tang J. W., & Chan R. C. W. (2004). Severe acute respiratory syndrome (SARS) in intensive care units (ICUs): limiting the risk to healthcare workers. Current Anaesthesia & Critical Care, 15(3): 143-155.
  70. Trinchero E. (2019). L’approccio sistemico alla gestione dei rischi in sanita. QUADERNI – Italian Journal of Medicine, 7(6): 1-7.
  71. Trinchero E. & Lega F. (2016). Governare la sala operatoria nell’ospedale del XXI secolo. Qualita, sicurezza, efficienza. Milano: Egea.
  72. Vatanpour S., Hrudey S. E., & Dinu I. (2015). Can public health risk assessment using risk matrices be misleading?. International Journal of Environmental Research and Public Health, 12(8): 9575-9588. Wang C., Cheng Z., Yue X. G., & McAleer M. (2020). Risk management of COVID-19 by universities in China. J. Risk Financial Manag., 13(2): 36.
  73. Xu K., Cai H., Shen Y., Ni Q., Chen Y., Hu S., ... & Qiu Y. (2020). Management of corona virus disease-19 (COVID-19): the Zhejiang experience. Journal of Zhejiang University (medical science), 49(1): 147-157.
  74. Yassi A., Moore D., FitzGerald J. M., Bigelow P., Hon M. C. Y., Bryce E., & BC Interdisciplinary Respiratory Protection Study Group (2005). Research gaps in protecting healthcare workers from SARS and other respiratory pathogens: an interdisciplinary, multi-stakeholder, evidence-based approach. Journal of occupational and environmental medicine, 47(1): 41.
  75. Yu I.T., Xie Z.H., Tsoi K.K. et al. (2007). Why did outbreaks of severe acute respiratory syn drome occur in some hospital wards but not in others?. Clin Infect Dis., 44(8): 1017-1025. DOI: 10.1086/512819
  76. Zangrandi A., Fanelli S., Lanza G., & Francesconi
  77. A. (2020). Imparare dall’esperienza Covid-19: l’importanza del coordinamento del territorio. Evidenze da una ricerca qualitativa. Mecosan, 113: 219-225. DOI: 10.3280/MESA2020-113027
  78. Zhu N., Zhang D., Wang W. et al. (2020). A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med, 382: 727-733.
  79. Zoia C., Bongetta D., Veiceschi P., Cenzato M., Di Meco F., Locatelli D., & Fontanella M. M. (2020). Neurosurgery during the COVID-19 pandemic: update from Lombardy, northern Italy. Acta Neurochirurgica, 162: 1221-1222.

Alessandro Capocchi, Paola Orlandini, Stefano Amelio, Hospital risk management at the time of Covid-19: An analysis of the Lombardy Region in "MECOSAN" 118/2021, pp 97-116, DOI: 10.3280/MESA2021-118005